Celia Lara-Morga Magda Palka-Kotlowska Sara Custodio-Cabello Vilma Pacheco-Barcia Luis Cabezón-Gutiérrez
10.37349/etat.2023.00136
Explor Target Antitumor Ther
2023;4(2):307-315.
complete response colorectal cancer trifluridine/tipiracil (tas-102)
CC BY
https://pubmed.ncbi.nlm.nih.gov/37205314/
Case Reports
PMC10185440
37205314
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma
2023